<SUBMISSION>
<SECRELEASE-DATETIME> 20221103-083927 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20221103-083913 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20221103-083831 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001562180-22-007459
<TYPE> 4
<PUBLIC-DOCUMENT-COUNT> 1
<PERIOD> 20221101
<FILING-DATE> 20221103
<DATE-OF-FILING-DATE-CHANGE> 20221103
|
<REPORTING-OWNER>
<OWNER-DATA>
<CONFORMED-NAME> Duker Jay S.
<CIK> 0001630864
</OWNER-DATA>
<FILING-VALUES>
<FORM-TYPE> 4
<ACT> 34
<FILE-NUMBER> 000-51122
<FILM-NUMBER> 221356410
</FILING-VALUES>
<MAIL-ADDRESS>
<STREET1> C/O ELEVEN BIOTHERAPEUTICS
<STREET2> 215 1ST ST. #400
<CITY> CAMBRIDGE
<STATE> MA
<ZIP> 02142
</MAIL-ADDRESS>
</REPORTING-OWNER>
|
<ISSUER>
<COMPANY-DATA>
<CONFORMED-NAME> EyePoint Pharmaceuticals, Inc.
<CIK> 0001314102
<ASSIGNED-SIC> 3826
<IRS-NUMBER> 262774444 ⇒ 26-2774444 or 262-77-4444
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<BUSINESS-ADDRESS>
<STREET1> 480 PLEASANT STREET
<STREET2> SUITE B300
<CITY> WATERTOWN
<STATE> MA
<ZIP> 02472
<PHONE> 617-926-5000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 480 PLEASANT STREET
<STREET2> SUITE B300
<CITY> WATERTOWN
<STATE> MA
<ZIP> 02472
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> pSivida Corp.
<DATE-CHANGED> 20080619
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> pSivida LTD
<DATE-CHANGED> 20050111
</FORMER-COMPANY>
</ISSUER>
|
<DOCUMENT>
<TYPE> 4
<SEQUENCE> 1
<FILENAME> primarydocument.xml
<DESCRIPTION> PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
Show <XML>: 186 lines (widest: 267 characters) - 8K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
